Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Seikagaku Corporation patents

Recent patent applications related to Seikagaku Corporation. Seikagaku Corporation is listed as an Agent/Assignee. Note: Seikagaku Corporation may have other listings under different names/spellings. We're not affiliated with Seikagaku Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Seikagaku Corporation-related inventors

Composition including glycosaminoglycan derivative and chemokine receptor activity regulator

Provided are a composition comprising a gag derivative and a chemokine receptor activity regulator, and a pharmaceutical composition comprising said composition.. . ... Seikagaku Corporation

Method for measuring zygomycota and reagent kit for measuring zygomycota

An object of the present invention is to provide means for correctly measuring zygomycota. The present inventors have found that conventionally difficult zygomycota measurement can be performed through subjecting an untreated specimen to an acid treatment. ... Seikagaku Corporation

Method for sulfating glycosaminoglycan

An object of the present invention is provide a method for sulfating a glycosaminoglycan in a solution of a non-organic solvent. In the present invention, sulfation reaction of a glycosaminoglycan is performed with a sulfating agent in a strongly basic solution of a non-organic solvent. ... Seikagaku Corporation

Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease

Provided is a chondroitin sulfate derivative having a structure cross-linked with a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. ... Seikagaku Corporation

Agent for improving ocular subjective symptoms and method thereof

. . Provided is an agent for improving human ocular subjective symptoms containing hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto.. . ... Seikagaku Corporation

Anti-chondroitin-sulfate-e antibody

. . The present invention provides an antibody that can react with chondroitin sulfate e at a high specificity and that can be used for, for example, the detection, isolation, and so forth, of specific sulfated polysaccharides. The present invention relates to a novel anti-chondroitin sulfate e antibody that reacts with chondroitin sulfate e and does not react with chondroitin sulfate a, does not react with chondroitin sulfate b, and does not react with chondroitin sulfate d.. ... Seikagaku Corporation

Therapeutic agent for disc herniation

. . . . The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disc herniation, which is characterized by containing chondroitinase abc as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk.. ... Seikagaku Corporation

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Seikagaku Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Seikagaku Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by